Research output per year
Research output per year
Personal profile
Memberships of committees and professional bodies
Qualifications
- PhD, The University of Manchester, 12/2016
- MSc Clinical Rheumatology (Merit), The University of Manchester, 09/2013
- MRCP Rheumatology Speciality Certificate Examination, 07/2013
- MRCP (UK), 11/2009
- MBBS, Queen Mary and Westfield College, St Bartholomew’s and the Royal London Medical School, The University of London, 07/2007
- BSc (Hons) Human Biosciences (Sensory Biochemistry) 1st Class Honours, Queen Mary and Westfield College, The University of London, 07/2006
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
WSF Digital Ulcer ad hoc committee Lead, World Scleroderma Foundation (WSF)
WSF Gastrointestinal ad hoc committee Co-Lead, World Scleroderma Foundation (WSF)
SCTC Orofacial in SSc Working Group Co-lead, Scleroderma Clinical Trials Consortium
UK Scleroderma Study Group (UKSSG) Member
Fingerprint
Dive into the research topics where Michael Hughes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation
Ciommo, F. R. D., Casciola-Rosen, L., Ayla, A. Y., Balar, A., Shah, A. A., Hughes, M., Morales, W., Pimentel, M., Adler, B. L. & McMahan, Z. H., 10 Jul 2025, In: Rheumatology.Research output: Contribution to journal › Article › peer-review
-
Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis
Ayla, A. Y., Kalavar, N. R., Pimentel, M., Morales, W., Hummers, L. K., Shah, A. A., Hughes, M. & McMahan, Z. H., 12 Apr 2025, In: Rheumatology.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon
Screm, G., Mondini, L., Salton, F., Confalonieri, P., Bozzi, C., Torregiani, C., Antonaglia, C., Geri, P., D'Oria, M., Giulia, G., Hughes, M., Confalonieri, M. & Ruaro, B., 2 Feb 2025, In: Pharmaceuticals. 18, 2, 203.Research output: Contribution to journal › Article › peer-review
Open Access -
Association between beta-1-adrenoceptor blockade and risk of Raynaud's phenomenon: Mendelian randomisation study
Williams, J. C., Rogers, K., Coulson, K., Hughes, D. M., Hughes, M. & Zhao, S. S., 1 Jun 2025, In: Journal of Scleroderma and Related Disorders. 10, 2, p. 151-155Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Avoidant Restrictive Food Intake Disorder Symptoms in Adults with Systemic Sclerosis: A Nationwide Study in Spain
Alcala‐Gonzalez, L. G., Burton‐Murray, H., Atkins, M., Guillen‐del‐Castillo, A., Malagelada, C., Hughes, M., McMahan, Z. & Simeón-Aznar, C. P., 29 Jun 2025, In: Arthritis Care & Research.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure)
Press/Media
-
MAIL ONLINE: At-home lamp can treat painful ulcers and varicose veins: Infrared and UV rays kill bacteria and reduce inflammation to promote wound healing
26/07/18
1 item of Media coverage
Press/Media: Research
Thesis
-
Digital ulcers in systemic sclerosis: investigating the outcome measures of treatment efficacy, pathophysiology, and the development of local treatments
Hughes, M. (Author), Roberts, C. (Supervisor), Herrick, A. (Supervisor) & Murray, A. (Supervisor), 4 Nov 2016Student thesis: Phd
File